GlycoMimetics (GLYC) Terminates $40M Common Stock Sales Agreement
Tweet Send to a Friend
GlycoMimetics (NASDAQ: GLYC) disclosed in an SEC filing:On May 23, 2017, GlycoMimetics, Inc. (the “Company”) terminated its Sales Agreement (the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
